The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more
Category - Precision medicine
From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
TL;DR 2025 shifted healthcare from experimentation to execution AI moved from tools to infrastructure 2026 will reward disciplined execution over vision Why this matters for precision medicine + generative AI This...read more
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Inside the Biology of 116 Years of Life: What Multiomics Reveals About Extreme Longevity
At enlightenbio, we are deeply committed to studying longevity and health span, which aligns with our personal and professional interests in biological science. For more on this, please see a couple of earlier...read more
